Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Feun

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Oncogene|June 23, 2015
Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agentsW-B Tsai, Y Long, J-R Park, et al.
Journal of the National Cancer Institute|November 15, 1995
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group studyF L Meyskens, K J Kopecky, C W Taylor, et al.
British Journal of Cancer|April 5, 2012
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminaseL G Feun, A Marini, G Walker, et al.
American Journal of Clinical Oncology|August 10, 1999
A phase I study of chemoembolization with cisplatin, thiotepa, and lipiodol for primary and metastatic liver cancerL G Feun, K R Reddy, T Scagnelli, et al.
Cancer|October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)L G Feun, J Gutterman, M A Burgess, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Oncogene|June 23, 2015
Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agentsW-B Tsai, Y Long, J-R Park, et al.
Journal of the National Cancer Institute|November 15, 1995
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group studyF L Meyskens, K J Kopecky, C W Taylor, et al.
British Journal of Cancer|April 5, 2012
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminaseL G Feun, A Marini, G Walker, et al.
American Journal of Clinical Oncology|August 10, 1999
A phase I study of chemoembolization with cisplatin, thiotepa, and lipiodol for primary and metastatic liver cancerL G Feun, K R Reddy, T Scagnelli, et al.
Cancer|October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)L G Feun, J Gutterman, M A Burgess, et al.
Pageof 9